NxStage Initial Public Offering

NxStage has filed an application with the SEC for an initial public offering. Their S-1 filing contains information which may be of interest to some and is available at:



Oh wow, I wonder whether we patients can invest into NxStage? What do you think? About $10.00 per share(estimate)…

Keep a lookout on the NXTM ticker… :wink:


NxStage CEO Jeffrey Burbank with the System One hemodialysis machine.

Stocks are available now! Woohoo… 8)

If memory serves, it went to $13.25 today, but closed at $12.68